Contrasts between mucormycosis and aspergillosis in oncohematological patients

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

(2018) A.J. Ullmann et al.   CLINICAL MICROBIOLOGY AND INFECTION

Challenges in the diagnosis and treatment of mucormycosis

(2018) A Skiada et al.   MEDICAL MYCOLOGY

Characteristics of culture-positive invasive pulmonary aspergillosis in patients with hematologic diseases

(2017) Sung-Yeon Cho et al.   MEDICINE

Increasing incidence of mucormycosis in a large Spanish hospital from 2007 to 2015: Epidemiology and microbiological characterization of the isolates

(2017) Jesús Guinea et al.   PLoS One

Prevalence, clinical and economic burden of mucormycosis-related hospitalizations in the United States: a retrospective study

(2016) Dimitrios P. Kontoyiannis et al.   BMC INFECTIOUS DISEASES

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

(2016) Johan A Maertens et al.   LANCET

Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study

(2016) Clara Mariette et al.   LEUKEMIA & LYMPHOMA

ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

(2016) Frederic Tissot et al.   HAEMATOLOGICA

Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis

(2015) J. Jung et al.   CLINICAL MICROBIOLOGY AND INFECTION

Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute

(2015) Joshua F. Zeidner et al.   JNCI-Journal of the National Cancer Institute

The burden of serious fungal diseases in Russia

(2015) N. Klimko et al.   MYCOSES

Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute

(2015) Joshua F. Zeidner et al.   JNCI-Journal of the National Cancer Institute

Application of the 2008 Definitions for Invasive Fungal Diseases to the Trial Comparing Voriconazole Versus Amphotericin B for Therapy of Invasive Aspergillosis: A Collaborative Study of the Mycoses Study Group (MSG 05) and the European Organization for Research and Treatment of Cancer Infectious Diseases Group

(2014) Raoul Herbrecht et al.   CLINICAL INFECTIOUS DISEASES

Mucormycosis in haematological patients: case report and results of prospective study in Saint Petersburg, Russia

(2014) Nikolay N. Klimko et al.   MYCOSES

The Reversed Halo Sign: Pathognomonic Pattern of Pulmonary Mucormycosis in Leukemic Patients With Neutropenia?

(2013) C. Legouge et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study

(2013) Russell E. Lewis et al.   MYCOSES

A Global Analysis of Mucormycosis in France: The RetroZygo Study (2005-2007)

(2012) F. Lanternier et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology and treatment outcome of invasive fungal infections in patients with hematological malignancies

(2012) Mitsutoshi Kurosawa et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry

(2012) William J. Steinbach et al.   JOURNAL OF INFECTION

Invasive Aspergillosis in Pediatric Oncology Patients: A Rare Event With Poor Prognosis - Case Analysis to Plan Better Targeted Prophylactic or Therapeutic Measurement

(2012) F. Babor et al.   KLINISCHE PADIATRIE

Mortality in Hematologic Malignancy and Hematopoietic Stem Cell Transplant Patients with Mucormycosis, 2001 to 2009

(2011) Sarah P. Hammond et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

The Diagnostic Value of Halo and Reversed Halo Signs for Invasive Mold Infections in Compromised Hosts

(2011) S. P. Georgiadou et al.   CLINICAL INFECTIOUS DISEASES

Invasive aspergillosis in patients with hematologic malignancies: incidence and description of 127 cases enrolled in a single institution prospective survey from 2004 to 2009

(2011) M.-C. Nicolle et al.   HAEMATOLOGICA

Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001–2006: Overview of the Transplant‐Associated Infection Surveillance Network (TRANSNET) Database

(2010) Dimitrios P. Kontoyiannis et al.   CLINICAL INFECTIOUS DISEASES

Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital

(2010) V. Saegeman et al.   MEDICAL MYCOLOGY

High rate of breakthrough invasive aspergillosis among patients receiving caspofungin for persistent fever and neutropenia

(2009) M. Lafaurie et al.   CLINICAL MICROBIOLOGY AND INFECTION

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

(2009) L. Pagano et al.   HAEMATOLOGICA

Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

(2008) Ben De Pauw et al.   CLINICAL INFECTIOUS DISEASES